Please Wait...

WebHeart Platform

WebHeart is a proprietary, web-based, validated, 21 CFR part 11 compliant and configurable platform for the management, processing, analysis and reporting of cardiovascular safety and efficacy data including ECG and hemodynamic endpoints. Access to cardiac safety data in real time via WebHeart enables rapid and informed decision making for your clinical trial.

Benefits of conducting your study within the WebHeart platform include:

  • Rapid and real-time management of study data via secure internet access
  • Configurable for sponsor-specific protocols
  • Compatibility with all ECG and ABPM technologies and operating systems
  • Centralized storage of cardiovascular data from both single center early phase trials to multicenter global studies
  • Role-based, 'rights-restricted' security model
  • Regulatory submission-ready ECG data
  • No special software, plug-ins, or add-ons required

Data Integrity and Security

WebHeart and associated processes have been developed and are continually enhanced to provide our sponsors with credible trial data that has been evaluated and managed within rigorous quality systems. WebHeart is 21CFR part 11 compliant and has successfully completed multiple external system audits. Disaster recovery and other data security considerations are built in to the platform and our SOPs.

Data Management and Analysis

One of WebHeart's principal features is a world class ECG processing system offering a complete solution for acquiring, displaying, measuring, and managing ECG data and is compatible with all collection sources (standard, hardcopy, and Holter extractions). WebHeart's primary function is to acquire, store, and display digital ECG images for cardiologist review, fiducial marker identification, interval measurements, findings entry, and image annotation. The system's capabilities include data management, scanning and digitization, audit trail maintenance, security functions, and provide digital ECG data for regulatory submission (FDA, EMA, PMDA, and CFDA).

Study Management

Throughout the course of a study, the Bioclinica study team uses WebHeart as the foundation for study tracking and reporting. All study related items (e.g. calls, open DCFs, closed DCFs, site trainings, site shipments, regulatory documents, etc.) are tracked in WebHeart® and can be continually exported for submission to the project team.

The WebHeart® system provides the following Study Management benefits:

  • Real-time access to study data and trial status
  • Continuous QA monitoring and reporting
  • Multi-layered security, using encryption, digital certificates, user, context, and role-based access control, and detailed auditing to ensure data safety and integrity
  • MCC metrics reporting based on sponsor specifications

ADDITIONAL RESOURCES

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Meet our expert Kevin Bishop to learn more about managing your supply chain risks with the right #RTSM solution.… https://t.co/8VCgN9UtfF
Bioclinica (8 hours ago)
IRT Support Specialist Seeking a project support specialist in Groton, CT - Great opportunity for those applying te… https://t.co/zytqY6f2o7
Bioclinica (2 days ago)
Attend Bioclinica's session at #OCTNE "When EDC is not enough" – and then visit us at booth #38! #bioclinica… https://t.co/5LgOV4heQ6
Bioclinica (4 days ago)
Looking for an #rtsm solution that reduces time, implementation effort and cost for complex global trials? Learn mo… https://t.co/2vh8MHEG28
Bioclinica (4 days ago)
Are site payment a challenge? Meet our expert Meghan Harrington to learn more about our Site & Patient Payments tec… https://t.co/16VOGA8mLV
Bioclinica (2 weeks ago)
With 25+ years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in pro… https://t.co/D3A2EMTqol
Bioclinica (2 weeks ago)